soul trial oral semaglutide cardiovascular outcomes results 2024 2025 nejm Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study soul trial oral semaglutide cardiovascular

Registered dietitian Ayla Barmmer told The New York Post that 15% of her GLP-1 patients have encountered fertility challenges, with 40% of that group experiencing irregular menstrual cycles, delayed ovulation, or declining sperm quality, outcomes likely tied to nutrient deficiencies resulting from rapid weight loss

Understanding Semaglutide Titration and Injection Frequency Titration is the foundation of safe and effective semaglutide therapy, designed to minimize nausea, vomiting, and other adaptation-related side effects while allowing your GLP-1 receptors to upregulate gradually

Semaglutide itself does not make you cold, but some of the medications intended effects such as weight loss and metabolic changes can cause some people to temporarily feel colder

Glp-1 Prevents Demyelination by Inhibiting Neuronal Inflammation Neuroinflammation plays a pivotal role in the progression of demyelinating diseases

For example, an increasing number of patients have reported constant vomiting, diarrhea, pancreatitis, gastroparesis and host of other life-altering side effects